Report Detail
Global Quetiapine Fumarate Market Growth 2019-2024
- RnM2851156 |
- 01 February, 2019 |
- Global |
- 163 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
Quetiapine Fumarate is an atypical antipsychotic drug used to treat psychiatric disorders such as schizophrenia, bipolar disorder and depression. It may be used alone or in combination with other psychiatric medications. It is taken orally, and is available only by prescription, under the supervision of a medical practitioner.
The Quetiapine Fumarate was developed by AstraZeneca from 1992 to 1996. It was first approved by the FDA in 1997.
The product is invented and first produced in the UK by AstraZeneca. AstraZeneca is also the leader of the Quetiapine Fumarate base drugs.
The Average gross of the industry is over 40%. However, since there are new companies coming into the area, the gross is declining in the last several years.
According to this study, over the next five years the Quetiapine Fumarate market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Quetiapine Fumarate business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Quetiapine Fumarate market by product type, application, key manufacturers and key regions and countries.
This study considers the Quetiapine Fumarate value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Immediate Release Tablets
Extended Release Tablets
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Application I
Application II
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
AstraZeneca
Intas
TAPI
Accord
Hexal
Dr.Reddy's
Lupin
Sun Pharmaceutical
Hunan Dongting Pharm
SuZhou NO.4 Phamaceutical Factory
Fuan Pharmaceutical
Zhejiang Supor Pharmaceuticals
Zhejiang Huahai Pharmaceutical
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Quetiapine Fumarate consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Quetiapine Fumarate market by identifying its various subsegments.
Focuses on the key global Quetiapine Fumarate manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Quetiapine Fumarate with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Quetiapine Fumarate submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Quetiapine Fumarate Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Quetiapine Fumarate Consumption 2014-2024
- 2.1.2 Quetiapine Fumarate Consumption CAGR by Region
- 2.2 Quetiapine Fumarate Segment by Type
- 2.2.1 Immediate Release Tablets
- 2.2.2 Extended Release Tablets
- 2.3 Quetiapine Fumarate Consumption by Type
- 2.3.1 Global Quetiapine Fumarate Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Quetiapine Fumarate Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Quetiapine Fumarate Sale Price by Type (2014-2019)
- 2.4 Quetiapine Fumarate Segment by Application
- 2.4.1 Application I
- 2.4.2 Application II
- 2.5 Quetiapine Fumarate Consumption by Application
- 2.5.1 Global Quetiapine Fumarate Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Quetiapine Fumarate Value and Market Share by Application (2014-2019)
- 2.5.3 Global Quetiapine Fumarate Sale Price by Application (2014-2019)
3 Global Quetiapine Fumarate by Players
- 3.1 Global Quetiapine Fumarate Sales Market Share by Players
- 3.1.1 Global Quetiapine Fumarate Sales by Players (2017-2019)
- 3.1.2 Global Quetiapine Fumarate Sales Market Share by Players (2017-2019)
- 3.2 Global Quetiapine Fumarate Revenue Market Share by Players
- 3.2.1 Global Quetiapine Fumarate Revenue by Players (2017-2019)
- 3.2.2 Global Quetiapine Fumarate Revenue Market Share by Players (2017-2019)
- 3.3 Global Quetiapine Fumarate Sale Price by Players
- 3.4 Global Quetiapine Fumarate Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Quetiapine Fumarate Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Quetiapine Fumarate Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Quetiapine Fumarate by Regions
- 4.1 Quetiapine Fumarate by Regions
- 4.1.1 Global Quetiapine Fumarate Consumption by Regions
- 4.1.2 Global Quetiapine Fumarate Value by Regions
- 4.2 Americas Quetiapine Fumarate Consumption Growth
- 4.3 APAC Quetiapine Fumarate Consumption Growth
- 4.4 Europe Quetiapine Fumarate Consumption Growth
- 4.5 Middle East & Africa Quetiapine Fumarate Consumption Growth
5 Americas
- 5.1 Americas Quetiapine Fumarate Consumption by Countries
- 5.1.1 Americas Quetiapine Fumarate Consumption by Countries (2014-2019)
- 5.1.2 Americas Quetiapine Fumarate Value by Countries (2014-2019)
- 5.2 Americas Quetiapine Fumarate Consumption by Type
- 5.3 Americas Quetiapine Fumarate Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Quetiapine Fumarate Consumption by Countries
- 6.1.1 APAC Quetiapine Fumarate Consumption by Countries (2014-2019)
- 6.1.2 APAC Quetiapine Fumarate Value by Countries (2014-2019)
- 6.2 APAC Quetiapine Fumarate Consumption by Type
- 6.3 APAC Quetiapine Fumarate Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Quetiapine Fumarate by Countries
- 7.1.1 Europe Quetiapine Fumarate Consumption by Countries (2014-2019)
- 7.1.2 Europe Quetiapine Fumarate Value by Countries (2014-2019)
- 7.2 Europe Quetiapine Fumarate Consumption by Type
- 7.3 Europe Quetiapine Fumarate Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Quetiapine Fumarate by Countries
- 8.1.1 Middle East & Africa Quetiapine Fumarate Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Quetiapine Fumarate Value by Countries (2014-2019)
- 8.2 Middle East & Africa Quetiapine Fumarate Consumption by Type
- 8.3 Middle East & Africa Quetiapine Fumarate Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Quetiapine Fumarate Distributors
- 10.3 Quetiapine Fumarate Customer
11 Global Quetiapine Fumarate Market Forecast
- 11.1 Global Quetiapine Fumarate Consumption Forecast (2019-2024)
- 11.2 Global Quetiapine Fumarate Forecast by Regions
- 11.2.1 Global Quetiapine Fumarate Forecast by Regions (2019-2024)
- 11.2.2 Global Quetiapine Fumarate Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Quetiapine Fumarate Forecast by Type
- 11.8 Global Quetiapine Fumarate Forecast by Application
12 Key Players Analysis
- 12.1 AstraZeneca
- 12.1.1 Company Details
- 12.1.2 Quetiapine Fumarate Product Offered
- 12.1.3 AstraZeneca Quetiapine Fumarate Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 AstraZeneca News
- 12.2 Intas
- 12.2.1 Company Details
- 12.2.2 Quetiapine Fumarate Product Offered
- 12.2.3 Intas Quetiapine Fumarate Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 Intas News
- 12.3 TAPI
- 12.3.1 Company Details
- 12.3.2 Quetiapine Fumarate Product Offered
- 12.3.3 TAPI Quetiapine Fumarate Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 TAPI News
- 12.4 Accord
- 12.4.1 Company Details
- 12.4.2 Quetiapine Fumarate Product Offered
- 12.4.3 Accord Quetiapine Fumarate Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 Accord News
- 12.5 Hexal
- 12.5.1 Company Details
- 12.5.2 Quetiapine Fumarate Product Offered
- 12.5.3 Hexal Quetiapine Fumarate Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 Hexal News
- 12.6 Dr.Reddy's
- 12.6.1 Company Details
- 12.6.2 Quetiapine Fumarate Product Offered
- 12.6.3 Dr.Reddy's Quetiapine Fumarate Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.6.4 Main Business Overview
- 12.6.5 Dr.Reddy's News
- 12.7 Lupin
- 12.7.1 Company Details
- 12.7.2 Quetiapine Fumarate Product Offered
- 12.7.3 Lupin Quetiapine Fumarate Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.7.4 Main Business Overview
- 12.7.5 Lupin News
- 12.8 Sun Pharmaceutical
- 12.8.1 Company Details
- 12.8.2 Quetiapine Fumarate Product Offered
- 12.8.3 Sun Pharmaceutical Quetiapine Fumarate Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.8.4 Main Business Overview
- 12.8.5 Sun Pharmaceutical News
- 12.9 Hunan Dongting Pharm
- 12.9.1 Company Details
- 12.9.2 Quetiapine Fumarate Product Offered
- 12.9.3 Hunan Dongting Pharm Quetiapine Fumarate Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.9.4 Main Business Overview
- 12.9.5 Hunan Dongting Pharm News
- 12.10 SuZhou NO.4 Phamaceutical Factory
- 12.10.1 Company Details
- 12.10.2 Quetiapine Fumarate Product Offered
- 12.10.3 SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.10.4 Main Business Overview
- 12.10.5 SuZhou NO.4 Phamaceutical Factory News
- 12.11 Fuan Pharmaceutical
- 12.12 Zhejiang Supor Pharmaceuticals
- 12.13 Zhejiang Huahai Pharmaceutical
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Quetiapine Fumarate . Industry analysis & Market Report on Quetiapine Fumarate is a syndicated market report, published as Global Quetiapine Fumarate Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Quetiapine Fumarate market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
